Clinical Trial Update: Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase 2 trial update for obe-cel in patients with severe, refractory systemic lupus erythematosus and active lupus nephritis; the study is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• obe-cel

Snippet

Sponsor: Autolus Limited | Conditions: Lupus Nephritis | Phase 2 | Status: NOT_YET_RECRUITING